Sarah Slater

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

Ian Chau, David Cunningham, David González et al. · The Lancet Oncology · 2013 · 723 citations · Full text

Oncology, Open-label Phase 3, Cancer Management +7

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling et al. · Nature Communications · 2020 · 191 citations · Full text

The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma

Justin Stebbing, Thomas Powles, Kirsty McPherson et al. · Lung Cancer · 2008 · 145 citations

Medicine, Pleural Disease, Oncology +3

Testosterone

Sarah Slater, R.T.D. Oliver · Drugs & Aging · 2000 · 98 citations